178 related articles for article (PubMed ID: 38505495)
1. A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours.
Scott JI; Gutkin S; Green O; Thompson EJ; Kitamura T; Shabat D; Vendrell M
Angew Chem Weinheim Bergstr Ger; 2021 Mar; 133(11):5763-5767. PubMed ID: 38505495
[TBL] [Abstract][Full Text] [Related]
2. A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours.
Scott JI; Gutkin S; Green O; Thompson EJ; Kitamura T; Shabat D; Vendrell M
Angew Chem Int Ed Engl; 2021 Mar; 60(11):5699-5703. PubMed ID: 33300671
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes.
Janiszewski T; Kołt S; Kaiserman D; Snipas SJ; Li S; Kulbacka J; Saczko J; Bovenschen N; Salvesen G; Drąg M; Bird PI; Kasperkiewicz P
J Biol Chem; 2020 Jul; 295(28):9567-9582. PubMed ID: 32439802
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging.
Liao N; Su L; Zheng Y; Zhao B; Wu M; Zhang D; Yang H; Liu X; Song J
Angew Chem Int Ed Engl; 2021 Sep; 60(38):20888-20896. PubMed ID: 34268865
[TBL] [Abstract][Full Text] [Related]
5. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
[TBL] [Abstract][Full Text] [Related]
6. A highly selective and sensitive chemiluminescent probe for leucine aminopeptidase detection
Wang B; Chen Z; Cen X; Liang Y; Tan L; Liang E; Zheng L; Zheng Y; Zhan Z; Cheng K
Chem Sci; 2022 Feb; 13(8):2324-2330. PubMed ID: 35310505
[TBL] [Abstract][Full Text] [Related]
7. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
[TBL] [Abstract][Full Text] [Related]
8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
9. Real-Time Tracking of
Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
Front Immunol; 2018; 9():825. PubMed ID: 29770131
[TBL] [Abstract][Full Text] [Related]
10. Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies.
Kitamura T
Essays Biochem; 2023 Sep; 67(6):1003-1014. PubMed ID: 37313600
[TBL] [Abstract][Full Text] [Related]
11. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.
Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z
Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H.
Feehan DD; Jamil K; Polyak MJ; Ogbomo H; Hasell M; Li SS; Xiang RF; Parkins M; Trapani JA; Harrison JJ; Mody CH
PLoS Pathog; 2022 Feb; 18(2):e1010325. PubMed ID: 35202434
[TBL] [Abstract][Full Text] [Related]
14. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
[TBL] [Abstract][Full Text] [Related]
15. Shaping of Natural Killer Cell Antitumor Activity by
Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
Front Immunol; 2017; 8():458. PubMed ID: 28491060
[TBL] [Abstract][Full Text] [Related]
16. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
17. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway.
Vermijlen D; Luo D; Froelich CJ; Medema JP; Kummer JA; Willems E; Braet F; Wisse E
J Leukoc Biol; 2002 Oct; 72(4):668-76. PubMed ID: 12377935
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
19. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Hu W; Wang G; Huang D; Sui M; Xu Y
Front Immunol; 2019; 10():1205. PubMed ID: 31214177
[TBL] [Abstract][Full Text] [Related]
20. Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.
Niavarani SR; Lawson C; Bakos O; Boudaud M; Batenchuk C; Rouleau S; Tai LH
BMC Cancer; 2019 Aug; 19(1):823. PubMed ID: 31429730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
